Access to Cancer Therapies Act of 2003

H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R 1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunospuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.588 Medicare Fairness for Organ Transplant Recipients Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R. 1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill)

Client expense: $1,474,129 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform

Client expense: $1,479,577 · Firm income: Not reported

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)

Client expense: $1,479,577 · Firm income: Not reported

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Client expense: $149,000 · Firm income: Not reported

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform

Client expense: $1,479,577 · Firm income: Not reported

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)

Client expense: $1,479,577 · Firm income: Not reported

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)

Client expense: $1,479,577 · Firm income: Not reported

H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform

Client expense: $1,479,577 · Firm income: Not reported